{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:22:45Z","timestamp":1794493365804,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/inf.0000000000000717","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T12:15:16Z","timestamp":1434197716000},"page":"858-864","source":"Crossref","is-referenced-by-count":49,"title":["The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage"],"prefix":"10.1097","volume":"34","author":[{"given":"Olivier","family":"Le Polain De Waroux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Flasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prieto-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Edmunds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210202","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"Pneumococcal Carriage Group. The fundamental link between pneumococcal carriage and disease.","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"R2-15-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","article-title":"Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects.","volume":"32","author":"Davis","year":"2013","journal-title":"Vaccine"},{"key":"R4-15-20210202","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/aje\/kwt156","article-title":"Using pneumococcal carriage data to monitor postvaccination changes in invasive disease.","volume":"178","author":"Weinberger","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"Suppl 2","key":"R5-15-20210202","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1097\/INF.0000000000000083","article-title":"Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.","volume":"33","author":"Fleming-Dutra","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R6-15-20210202","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/00006454-199711000-00011","article-title":"Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.","volume":"16","author":"Dagan","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R7-15-20210202","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00006454-200005000-00014","article-title":"Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants.","volume":"19","author":"Obaro","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R8-15-20210202","first-page":"236","article-title":"Nasopharyngeal (NP) carriage of Streptococcus pneumoniae (Pnc) in toddlers vaccinated during infancy with an 11 valent pneumococcal vaccine conjugated to diphtheria and tetanus toxoids (PCV-DT).","volume":"40","author":"Dagan","year":"2000","journal-title":"Abstracts of the Interscience Conference on Antimicrobial Agents Chemotherapy"},{"key":"R9-15-20210202","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/339525","article-title":"Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.","volume":"185","author":"Dagan","year":"2002","journal-title":"J Infect Dis"},{"key":"R10-15-20210202","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/521833","article-title":"Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.","volume":"196","author":"OBrien","year":"2007","journal-title":"J Infect Dis"},{"key":"R11-15-20210202","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/jis447","article-title":"Rates of acquisition and clearance of pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya.","volume":"206","author":"Abdullahi","year":"2012","journal-title":"J Infect Dis"},{"key":"R12-15-20210202","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/EDE.0b013e31824f2f32","article-title":"Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.","volume":"23","author":"Lipsitch","year":"2012","journal-title":"Epidemiology"},{"key":"R13-15-20210202","doi-asserted-by":"crossref","first-page":"e38271","DOI":"10.1371\/journal.pone.0038271","article-title":"A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border.","volume":"7","author":"Turner","year":"2012","journal-title":"PLoS One"},{"key":"R14-15-20210202","doi-asserted-by":"crossref","first-page":"e28435","DOI":"10.1371\/journal.pone.0028435","article-title":"Using the indirect cohort design to estimate the effectiveness of the seven valent pneumococcal conjugate vaccine in England and Wales.","volume":"6","author":"Andrews","year":"2011","journal-title":"PLoS One"},{"key":"R16-15-20210202","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1016\/j.vaccine.2009.04.009","article-title":"Estimation of vaccine efficacy against acquisition of pneumococcal carriage.","volume":"27","author":"Rinta-Kokko","year":"2009","journal-title":"Vaccine"},{"key":"R17-15-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vaccine.2013.08.061","article-title":"Pneumococcal Carriage Group (PneumoCarr). Colonisation endpoints in Streptococcus pneumoniae vaccine trials.","volume":"32","author":"Auranen","year":"2013","journal-title":"Vaccine"},{"key":"R18-15-20210202","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R19-15-20210202","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1128\/CVI.00117-10","article-title":"Pneumococcal nasopharyngeal carriage following reduced doses of a 7-valent pneumococcal conjugate vaccine and a 23-valent pneumococcal polysaccharide vaccine booster.","volume":"17","author":"Russell","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"R20-15-20210202","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/adc.88.3.211","article-title":"Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy.","volume":"88","author":"Lakshman","year":"2003","journal-title":"Arch Dis Child"},{"key":"R23-15-20210202","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1097\/01.inf.0000232705.49634.68","article-title":"Kalgoorlie Otitis Media Research Project Team. Upper respiratory tract bacterial carriage in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia.","volume":"25","author":"Watson","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R24-15-20210202","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.vaccine.2009.09.113","article-title":"Effect of vaccination with pneumococcal capsular polysaccharides conjugated to Haemophilus influenzae-derived protein D on nasopharyngeal carriage of Streptococcus pneumoniae and H. influenzae in children under 2 years of age.","volume":"28","author":"Prymula","year":"2009","journal-title":"Vaccine"},{"key":"R26-15-20210202","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.vaccine.2010.12.086","article-title":"Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage.","volume":"29","author":"Prymula","year":"2011","journal-title":"Vaccine"},{"key":"R27-15-20210202","doi-asserted-by":"crossref","first-page":"e85001","DOI":"10.1371\/journal.pone.0085001","article-title":"Pneumococcal carriage in sub-Saharan Africa-a systematic review.","volume":"9","author":"Usuf","year":"2014","journal-title":"PLoS One"},{"key":"R28-15-20210202","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1016\/j.vaccine.2012.05.059","article-title":"The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.","volume":"30","author":"Dagan","year":"2012","journal-title":"Vaccine"},{"key":"R29-15-20210202","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/INF.0b013e3181a78185","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.","volume":"28","author":"Cheung","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R30-15-20210202","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/378744","article-title":"Finnish Otitis Media Study Group. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.","volume":"37","author":"Kilpi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R31-15-20210202","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1086\/522164","article-title":"Long-term effect of pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniaeand associated interactions with Staphylococcus aureus and Haemophilus influenzae colonizationin HIV-Infected and HIV-uninfected children.","volume":"196","author":"Madhi","year":"2007","journal-title":"J infect Dis"},{"key":"R32-15-20210202","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/315009","article-title":"Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine.","volume":"180","author":"Mbelle","year":"1999","journal-title":"J infect Dis"},{"key":"R33-15-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1086\/504802","article-title":"Effect of community-wide conjugate pneumococcal vaccine use in infancy on nasopharyngeal carriage through 3 years of age: a cross-sectional study in a high-risk population.","volume":"43","author":"Millar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R35-15-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.2009.975","article-title":"Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.","volume":"302","author":"van Gils","year":"2009","journal-title":"JAMA"},{"key":"R36-15-20210202","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0264-410X(03)00039-2","article-title":"Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants.","volume":"21","author":"Yeh","year":"2003","journal-title":"Vaccine"},{"key":"R37-15-20210202","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1016\/j.vaccine.2006.09.019","article-title":"Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immunodeficient virus infected and non-infected children in the absence of a booster dose of vaccine.","volume":"25","author":"Madhi","year":"2007","journal-title":"Vaccine"},{"key":"R38-15-20210202","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1128\/IAI.01673-06","article-title":"Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.","volume":"75","author":"Ekstrom","year":"2007","journal-title":"Infect Immun"},{"key":"R39-15-20210202","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1473-3099(14)70822-9","article-title":"Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.","volume":"14","author":"Andrews","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R40-15-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/CVI.00039-13","article-title":"FinOM Study Group. Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy.","volume":"20","author":"Ekstrom","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"R41-15-20210202","doi-asserted-by":"crossref","first-page":"e91413","DOI":"10.1371\/journal.pone.0091413","article-title":"Pneumococcal serotype-specific antibodies persist through early childhood after infant immunization: follow-up from a randomized controlled trial.","volume":"9","author":"Truck","year":"2014","journal-title":"PLoS One"},{"key":"R42-15-20210202","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1128\/IAI.00165-06","article-title":"Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.","volume":"74","author":"Zhang","year":"2006","journal-title":"Infect Immun"},{"key":"R44-15-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(06)69637-2","article-title":"Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.","volume":"368","author":"Whitney","year":"2006","journal-title":"Lancet"},{"key":"R45-15-20210202","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/CVI.00062-10","article-title":"Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.","volume":"17","author":"Esposito","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 2","key":"R46-15-20210202","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1097\/INF.0000000000000081","article-title":"The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.","volume":"33","author":"Park","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R47-15-20210202","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/INF.0b013e3181faa6be","article-title":"Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial.","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R48-15-20210202","doi-asserted-by":"crossref","first-page":"e74906","DOI":"10.1371\/journal.pone.0074906","article-title":"Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.","volume":"8","author":"Grant","year":"2013","journal-title":"PLoS One"},{"key":"R49-15-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.vaccine.2013.06.105","article-title":"Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.","volume":"32","author":"Auranen","year":"2013","journal-title":"Vaccine"},{"key":"R50-15-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(03)14022-6","article-title":"Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.","volume":"362","author":"OBrien","year":"2003","journal-title":"Lancet"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:07:03Z","timestamp":1620954423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201508000-00015"}},"subtitle":["A Meta-regression Model"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000717","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}